Managing Survivorship after Hematopoietic Cell Transplantation
Author:
- 30 March 2023
- journal article
- review article
- Published by Springer Nature in Current Hematologic Malignancy Reports
- Vol. 18 (3) , 75-82
Abstract
Purpose of Review With improvement in survival after hematopoietic cell transplantation (HCT), it has become important to focus on the late complications experienced by the survivors that may lead to late mortality and morbidity to be able to provide patient-centered care across the transplant continuum. The goals of this article are to describe the status of literature on late complications in HCT survivors; offer a brief overview of the status of the screening, prevention, and management of these complications; and identify opportunities for future practice and research. Recent Findings This is an exciting time for the field with increasing awareness about survivorship issues. Studies are moving beyond description to examining pathogenesis of these late complications and identifying biomarkers. The eventual goal is to promote changes in our transplant techniques to decrease the incidence of these complications as well as help develop interventions targeting these late effects. There is also an emphasis on improving health care delivery models to provide optimal post-HCT management for medical and psychosocial complications through close coordination between multiple stakeholders and leveraging technology to help address the barriers in delivery of care to fulfill the unmet needs in this area. Summary The increasing population of HCT survivors with their burden of late effects underscores the need for concerted efforts to improve long-term medical and psychosocial outcomes for this group.Keywords
This publication has 34 references indexed in Scilit:
- National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group ReportTransplantation and Cellular Therapy, 2017
- Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2017
- Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group ReportTransplantation and Cellular Therapy, 2016
- Perceived social support and health‐related quality of life in AYA cancer survivors and controlsPsycho-Oncology, 2016
- Prevalence of Hematopoietic Cell Transplant Survivors in the United StatesTransplantation and Cellular Therapy, 2013
- Nonmalignant Late Effects and Compromised Functional Status in Survivors of Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2012
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2011
- Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concernsBlood, 2010
- Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell TransplantationJournal of Clinical Oncology, 2010
- Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor StudyBlood, 2007